TABLE 2.
Age |
Height |
Weight |
Midupper arm circumference |
Triceps skinfold thickness |
||||||
Time point | Calcium | Placebo | Calcium | Placebo | Calcium | Placebo | Calcium | Placebo | Calcium | Placebo |
y | cm | kg | cm | mm | ||||||
Y1 | 10.1 ± 0.2 | 10.0 ± 0.2 | 132.6 ± 1.3 | 130.7 ± 1.2 | 25.4 ± 0.7 | 24.5 ± 0.7 | 18.5 ± 0.3 | 18.2 ± 0.3 | 8.8 ± 0.3 | 8.7 ± 0.4 |
Y2 | 11.2 ± 0.2 | 11.1 ± 0.2 | 138.1 ± 1.6 | 136.4 ± 1.2 | 28.1 ± 0.9 | 26.7 ± 0.8 | 19.6 ± 0.3 | 19.1 ± 0.3 | 9.6 ± 0.4 | 9.8 ± 0.5 |
Y3 | 12.1 ± 0.2 | 12.1 ± 0.2 | 143.6 ± 1.4 | 141.6 ± 1.4 | 31.7 ± 1.2 | 30.1 ± 1.0 | 20.5 ± 0.4 | 20.0 ± 0.3 | 9.4 ± 0.5 | 9.6 ± 0.5 |
Y4 | 13.2 ± 0.2 | 13.1 ± 0.2 | 148.5 ± 1.4 | 146.9 ± 1.4 | 36.2 ± 1.4 | 33.9 ± 1.2 | 22.2 ± 0.5 | 21.1 ± 0.4 | 10.3 ± 0.6 | 9.5 ± 0.5 |
Y6 | 15.2 ± 0.2 | 15.1 ± 0.2 | 157.0 ± 1.1 | 155.7 ± 1.1 | 44.6 ± 1.4 | 43.2 ± 1.3 | 21.9 ± 0.5 | 21.5 ± 0.4 | 10.5 ± 0.7 | 10.1 ± 0.5 |
Y8 | 17.1 ± 0.2 | 17.0 ± 0.2 | 160.5 ± 0.8 | 159.3 ± 0.9 | 50.7 ± 1.2 | 49.8 ± 1.0 | 24.1 ± 0.5 | 23.6 ± 0.4 | 12.8 ± 0.7 | 12.0 ± 0.7 |
Y10 | 19.0 ± 0.2 | 18.9 ± 0.2 | 161.5 ± 0.8 | 160.5 ± 1.2 | 53.6 ± 1.3 | 52.5 ± 1.3 | 25.3 ± 0.6 | 24.6 ± 0.5 | 14.1 ± 1.1 | 13.6 ± 1.2 |
Y12/11 | 20.6 ± 0.2 | 20.5 ± 0.3 | 162.8 ± 0.8 | 161.1 ± 1.1 | 53.5 ± 1.2 | 53.9 ± 1.7 | 24.8 ± 0.8 | 25.4 ± 0.5 | 13.6 ± 0.8 | 14.2 ± 1.0 |
Y14/13 | 22.9 ± 0.2 | 23.0 ± 0.3 | 163.0 ± 0.9 | 162.0 ± 1.1 | 54.6 ± 1.5 | 52.9 ± 1.2 | 25.9 ± 0.6 | 25.3 ± 0.5 | 13.4 ± 1.0 | 12.5 ± 1.1 |
All values are means ± SEMs. The numbers of girls in the calcium and placebo groups, respectively, were as follows: 40 and 40 at Y1–4, 38 and 39 at Y6, 39 and 40 at Y8, 29 and 25 at Y10, 33 and 30 at Y12/11, and 25 and 29 at Y14/13. There were no significant group differences by multiple regression analysis after adjustment for value and age at Y1, all P > 0.1. Y1, baseline; Y2–14, the year of follow-up relative to Y1.